Epigenetic Age and the Risk of Incident Atrial Fibrillation.


Journal

Circulation
ISSN: 1524-4539
Titre abrégé: Circulation
Pays: United States
ID NLM: 0147763

Informations de publication

Date de publication:
14 12 2021
Historique:
pubmed: 1 10 2021
medline: 8 1 2022
entrez: 30 9 2021
Statut: ppublish

Résumé

The most prominent risk factor for atrial fibrillation (AF) is chronological age; however, underlying mechanisms are unexplained. Algorithms using epigenetic modifications to the human genome effectively predict chronological age. Chronological and epigenetic predicted ages may diverge in a phenomenon referred to as epigenetic age acceleration (EAA), which may reflect accelerated biological aging. We sought to evaluate for associations between epigenetic age measures and incident AF. Measures for 4 epigenetic clocks (Horvath, Hannum, DNA methylation [DNAm] PhenoAge, and DNAm GrimAge) and an epigenetic predictor of PAI-1 (plasminogen activator inhibitor-1) levels (ie, DNAm PAI-1) were determined for study participants from 3 population-based cohort studies. Cox models evaluated for associations with incident AF and results were combined via random-effects meta-analyses. Two-sample summary-level Mendelian randomization analyses evaluated for associations between genetic instruments of the EAA measures and AF. Among 5600 participants (mean age, 65.5 years; female, 60.1%; Black, 50.7%), there were 905 incident AF cases during a mean follow-up of 12.9 years. Unadjusted analyses revealed all 4 epigenetic clocks and the DNAm PAI-1 predictor were associated with statistically significant higher hazards of incident AF, though the magnitudes of their point estimates were smaller relative to the associations observed for chronological age. The pooled EAA estimates for each epigenetic measure, with the exception of Horvath EAA, were associated with incident AF in models adjusted for chronological age, race, sex, and smoking variables. After multivariable adjustment for additional known AF risk factors that could also potentially function as mediators, pooled EAA measures for 2 clocks remained statistically significant. Five-year increases in EAA measures for DNAm GrimAge and DNAm PhenoAge were associated with 19% (adjusted hazard ratio [HR], 1.19 [95% CI, 1.09-1.31]; Our study identified adjusted associations between EAA measures and incident AF, suggesting that biological aging plays an important role independent of chronological age, though a potential underlying causal relationship remains unclear. These aging processes may be modifiable and not constrained by the immutable factor of time.

Sections du résumé

BACKGROUND
The most prominent risk factor for atrial fibrillation (AF) is chronological age; however, underlying mechanisms are unexplained. Algorithms using epigenetic modifications to the human genome effectively predict chronological age. Chronological and epigenetic predicted ages may diverge in a phenomenon referred to as epigenetic age acceleration (EAA), which may reflect accelerated biological aging. We sought to evaluate for associations between epigenetic age measures and incident AF.
METHODS
Measures for 4 epigenetic clocks (Horvath, Hannum, DNA methylation [DNAm] PhenoAge, and DNAm GrimAge) and an epigenetic predictor of PAI-1 (plasminogen activator inhibitor-1) levels (ie, DNAm PAI-1) were determined for study participants from 3 population-based cohort studies. Cox models evaluated for associations with incident AF and results were combined via random-effects meta-analyses. Two-sample summary-level Mendelian randomization analyses evaluated for associations between genetic instruments of the EAA measures and AF.
RESULTS
Among 5600 participants (mean age, 65.5 years; female, 60.1%; Black, 50.7%), there were 905 incident AF cases during a mean follow-up of 12.9 years. Unadjusted analyses revealed all 4 epigenetic clocks and the DNAm PAI-1 predictor were associated with statistically significant higher hazards of incident AF, though the magnitudes of their point estimates were smaller relative to the associations observed for chronological age. The pooled EAA estimates for each epigenetic measure, with the exception of Horvath EAA, were associated with incident AF in models adjusted for chronological age, race, sex, and smoking variables. After multivariable adjustment for additional known AF risk factors that could also potentially function as mediators, pooled EAA measures for 2 clocks remained statistically significant. Five-year increases in EAA measures for DNAm GrimAge and DNAm PhenoAge were associated with 19% (adjusted hazard ratio [HR], 1.19 [95% CI, 1.09-1.31];
CONCLUSIONS
Our study identified adjusted associations between EAA measures and incident AF, suggesting that biological aging plays an important role independent of chronological age, though a potential underlying causal relationship remains unclear. These aging processes may be modifiable and not constrained by the immutable factor of time.

Identifiants

pubmed: 34587750
doi: 10.1161/CIRCULATIONAHA.121.056456
pmc: PMC8671333
mid: NIHMS1754300
doi:

Types de publication

Clinical Trial Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1899-1911

Subventions

Organisme : NHLBI NIH HHS
ID : RC2 HL102419
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL103612
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL139731
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL120393
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL080295
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201500001C
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL087652
Pays : United States
Organisme : American Heart Association-American Stroke Association
ID : 16EIA26410001
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201500001I
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC85083
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700003I
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC85081
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG060908
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK062413
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL092577
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL130114
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268200800007C
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS087541
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000124
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC55222
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL128914
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC85086
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL105756
Pays : United States
Organisme : NHLBI NIH HHS
ID : K08 HL116640
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK063491
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700002C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201200036C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201800001C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700001I
Pays : United States
Organisme : NHLBI NIH HHS
ID : K24 HL148521
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700004I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700005C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700001C
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC85082
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700003C
Pays : United States
Organisme : NHLBI NIH HHS
ID : 75N92019D00031
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700004C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700002I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700005I
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC85079
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG023629
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001881
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC85080
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL141989
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL111089
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL116747
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL092111
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

Am J Epidemiol. 1989 Apr;129(4):687-702
pubmed: 2646917
Circulation. 2016 Feb 9;133(6):601-9
pubmed: 26858290
Circ Cardiovasc Qual Outcomes. 2012 Jan;5(1):85-93
pubmed: 22235070
Circ Res. 2018 Mar 2;122(5):752-773
pubmed: 29496798
PLoS Genet. 2012;8(4):e1002629
pubmed: 22532803
Nat Genet. 2018 Sep;50(9):1225-1233
pubmed: 29892015
Stat Med. 1997 Jul 15;16(13):1515-27
pubmed: 9249922
Aging (Albany NY). 2019 Jan 21;11(2):303-327
pubmed: 30669119
Science. 2018 Sep 28;361(6409):1336-1340
pubmed: 30262495
Stroke. 1991 Aug;22(8):983-8
pubmed: 1866765
Genome Biol. 2012 Jun 15;13(6):R44
pubmed: 22703947
Am Heart J. 2009 Jul;158(1):111-7
pubmed: 19540400
Biokhimiia. 1967 Sep-Oct;32(5):988-93
pubmed: 5628601
Am J Epidemiol. 1979 Sep;110(3):281-90
pubmed: 474565
BMC Bioinformatics. 2012 May 08;13:86
pubmed: 22568884
Nat Rev Genet. 2018 Jun;19(6):371-384
pubmed: 29643443
Circ Arrhythm Electrophysiol. 2014 Dec;7(6):1026-32
pubmed: 25381796
Aging (Albany NY). 2018 Apr 18;10(4):573-591
pubmed: 29676998
Ann Epidemiol. 1991 Feb;1(3):263-76
pubmed: 1669507
J Am Coll Cardiol. 2020 Mar 3;75(8):919-930
pubmed: 32130928
J Am Geriatr Soc. 2016 Apr;64(4):838-43
pubmed: 26926559
Circulation. 1998 Sep 8;98(10):946-52
pubmed: 9737513
Elife. 2018 May 30;7:
pubmed: 29846171
Mol Cell. 2013 Jan 24;49(2):359-367
pubmed: 23177740
Aging Cell. 2015 Aug;14(4):497-510
pubmed: 25902704
Nat Genet. 2018 Sep;50(9):1234-1239
pubmed: 30061737
J Am Heart Assoc. 2017 Nov 14;6(11):
pubmed: 29138179
Oncogene. 2013 Nov 21;32(47):5421-8
pubmed: 23686312
Circ Res. 2017 Apr 28;120(9):1501-1517
pubmed: 28450367
Int J Epidemiol. 2015 Apr;44(2):512-25
pubmed: 26050253
Front Genet. 2018 Jan 12;8:232
pubmed: 29379519
Aging Cell. 2019 Dec;18(6):e13028
pubmed: 31496122
Genome Biol. 2021 Jun 29;22(1):194
pubmed: 34187551
Ann Epidemiol. 1993 Jul;3(4):358-66
pubmed: 8275211
Aging (Albany NY). 2017 Feb 14;9(2):419-446
pubmed: 28198702
Circulation. 2011 Apr 12;123(14):1501-8
pubmed: 21444879
Science. 1983 Jun 3;220(4601):1055-7
pubmed: 6844925
JAMA. 2008 Jun 25;299(24):2877-83
pubmed: 18577732
Science. 2015 Dec 4;350(6265):1193-8
pubmed: 26785477
Genome Biol. 2013;14(10):R115
pubmed: 24138928
Epigenetics Chromatin. 2017 Apr 11;10:18
pubmed: 28413449

Auteurs

Jason D Roberts (JD)

Population Health Research Institute (J.D.R., P.M-S., G.P.).
Section of Cardiac Electrophysiology, Division of Cardiology, Department of Medicine, Western University, London, ON, Canada (J.D.R., A.C.S.).

Eric Vittinghoff (E)

Department of Epidemiology and Biostatistics (E.V.) University of California, San Francisco.

Ake T Lu (AT)

Department of Human Genetics, David Geffen School of Medicine (A.T.L., S.H.); University of California, Los Angeles.

Alvaro Alonso (A)

Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA (A.A.).

Biqi Wang (B)

Framingham Heart Study, Framingham, MA (B.W., J.K., H.L., E.J.B.).
Departments of Biostatistics (B.W., K.L.L.), School of Public Health.

Colleen M Sitlani (CM)

Cardiovascular Health Research Unit (C.M.S., J.A.B., S.R.H., T.M.B., N.S.).
Medicine (C.M.S., J.A.B., T.M.B., N.S.); University of Washington, Seattle.

Pedrum Mohammadi-Shemirani (P)

Population Health Research Institute (J.D.R., P.M-S., G.P.).
Departments of Medical Sciences (P.M-S.), McMaster University, Hamilton, ON, Canada.
Thrombosis and Atherosclerosis Research Institute, Department of Medicine, David Braley Cardiac, Vascular, and Stroke Research Institute (P.M-S., G.P.); McMaster University, Hamilton, ON, Canada.

Myriam Fornage (M)

Brown Foundation Institute of Molecular Medicine, McGovern Medical School, University of Texas Health Science Center at Houston (M.F.).

Jelena Kornej (J)

Framingham Heart Study, Framingham, MA (B.W., J.K., H.L., E.J.B.).
Sections of Cardiovascular Medicine (J.K., E.J.B.), Department of Medicine, School of Medicine; Boston University, MA.

Jennifer A Brody (JA)

Cardiovascular Health Research Unit (C.M.S., J.A.B., S.R.H., T.M.B., N.S.).
Medicine (C.M.S., J.A.B., T.M.B., N.S.); University of Washington, Seattle.

Dan E Arking (DE)

McKusick-Nathans Institute, Department of Genetic Medicine, Baltimore, MD (D.E.A.).

Honghuang Lin (H)

Framingham Heart Study, Framingham, MA (B.W., J.K., H.L., E.J.B.).
Computational Biomedicine (H.L.), Department of Medicine, School of Medicine; Boston University, MA.

Susan R Heckbert (SR)

Cardiovascular Health Research Unit (C.M.S., J.A.B., S.R.H., T.M.B., N.S.).
Departments of Epidemiology (S.R.H., N.S.), University of Washington, Seattle.

Ivana Prokic (I)

Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands (I.P., M.G.).

Mohsen Ghanbari (M)

Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands (I.P., M.G.).

Allan C Skanes (AC)

Section of Cardiac Electrophysiology, Division of Cardiology, Department of Medicine, Western University, London, ON, Canada (J.D.R., A.C.S.).

Traci M Bartz (TM)

Cardiovascular Health Research Unit (C.M.S., J.A.B., S.R.H., T.M.B., N.S.).
Biostatistics (T.M.B.), University of Washington, Seattle.
Medicine (C.M.S., J.A.B., T.M.B., N.S.); University of Washington, Seattle.

Marco V Perez (MV)

Division of Cardiovascular Medicine, Stanford University School of Medicine, CA (M.V.P.).

Kent D Taylor (KD)

Institute for Translational Genomics, The Lundquist Institute at Harbour-University of California, Los Angeles Medical Center, Torrance, CA (K.D.T.).

Steven A Lubitz (SA)

Cardiovascular Research Center (S.A.L., P.T.E.); Massachusetts General Hospital, Boston.
Cardiac Arrhythmia Service (S.A.L., P.T.E.), Massachusetts General Hospital, Boston.
Program in Medical and Population Genetics, Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge (S.A.L., P.T.E.).

Patrick T Ellinor (PT)

Cardiovascular Research Center (S.A.L., P.T.E.); Massachusetts General Hospital, Boston.
Cardiac Arrhythmia Service (S.A.L., P.T.E.), Massachusetts General Hospital, Boston.
Program in Medical and Population Genetics, Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge (S.A.L., P.T.E.).

Kathryn L Lunetta (KL)

Departments of Biostatistics (B.W., K.L.L.), School of Public Health.

James S Pankow (JS)

Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis (J.S.P.).

Guillaume Paré (G)

Population Health Research Institute (J.D.R., P.M-S., G.P.).
Pathology and Molecular Medicine (G.P.); McMaster University, Hamilton, ON, Canada.
Thrombosis and Atherosclerosis Research Institute, Department of Medicine, David Braley Cardiac, Vascular, and Stroke Research Institute (P.M-S., G.P.); McMaster University, Hamilton, ON, Canada.

Nona Sotoodehnia (N)

Cardiovascular Health Research Unit (C.M.S., J.A.B., S.R.H., T.M.B., N.S.).
Division of Cardiology (N.S.).
Departments of Epidemiology (S.R.H., N.S.), University of Washington, Seattle.
Medicine (C.M.S., J.A.B., T.M.B., N.S.); University of Washington, Seattle.

Emelia J Benjamin (EJ)

Framingham Heart Study, Framingham, MA (B.W., J.K., H.L., E.J.B.).
Epidemiology (E.J.B.), School of Public Health.
Sections of Cardiovascular Medicine (J.K., E.J.B.), Department of Medicine, School of Medicine; Boston University, MA.

Steve Horvath (S)

Department of Biostatistics, School of Public Health (S.H.); University of California, Los Angeles.

Gregory M Marcus (GM)

Section of Cardiac Electrophysiology, Division of Cardiology, Department of Medicine (G.M.M.); University of California, San Francisco.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH